Business Context and Reporting Period
This Form 6-K filing by Lloyds TSB Group plc (now Lloyds Banking Group Plc) is a regulatory notification dated 20 October 2006. The document serves as a disclosure of transactions involving directors and persons discharging managerial responsibilities (PDMR) in accordance with UK regulatory rules (DR 3.1.4R(1)) and the Companies Act 1985. It does not contain financial results or operational updates for a specific reporting period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a compliance notification regarding shareholdings and does not include financial statements or performance metrics.
Material Changes
The filing details a specific transaction involving Mr. Archibald Gerard Kane, a director of the company:
- Transaction Type: Purchase of 23 Ordinary Shares of 25p each.
- Date of Transaction: 4 October 2006.
- Price: 549.99 pence per share.
- Context: The shares were purchased by Lloyds TSB Registrars (ISA) Nominees Limited for Mr. Kane's single company maxi ISA. The director was unaware of the transaction until notified by the registrar and reported it to the company immediately upon receipt of information.
- Impact: The percentage of the issued class acquired is described as minimal.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, or discussion of risks and contingencies. The only unusual item noted is the delayed notification of the share purchase due to the director's lack of immediate awareness of the ISA transaction executed by the nominee.
Investor Verification Checklist
- Verify the total shareholding of Mr. Archibald Gerard Kane, which includes direct holdings, holdings via his spouse, nominee accounts, and conditional awards under performance and long-term incentive plans.
- Confirm the total number of options held by the director following this notification, stated as 1,587,003.
- Note that this filing is a routine regulatory disclosure and does not reflect changes in the company's financial health or strategic direction.